Precision psychiatry
- PMID: 34190828
- PMCID: PMC9041961
- DOI: 10.1590/1516-4446-2021-1997
Precision psychiatry
Conflict of interest statement
AS is or has been a consultant to or has received honoraria or grants unrelated to the present work from: Abbott, AbbVie, Angelini, AstraZeneca, Clinical Data, Boehringer, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Innova Pharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polifarma, Sanofi, Servier, and Taliaz.
References
-
- Zanardi R, Prestifilippo D, Fabbri C, Colombo C, Maron E, Serretti A. Precision psychiatry in clinical practice. Int J Psychiatry Clin Pract. 2021;25:19–27. - PubMed
-
- Fanelli G, Benedetti F, Kasper S, Zohar J, Souery D, Montgomery S, et al. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2021;108:110170. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical